Yan Li
37Patents
9h-index
79Co-inventors
78Inventor score
Filing activity: Aug 12, 1999 → Jan 30, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7132259B1 | Activatable recombinant neurotoxins | Emerging Cross-Sectional Technologies | 77 | Expired |
| US7419676B2 | Activatable recombinant neurotoxins | Emerging Cross-Sectional Technologies | 64 | Expired |
| US7455983B2 | Medium for growing human embryonic stem cells | Chemistry; Metallurgy | 48 | Expired |
| US7422877B2 | Activatable recombinant neurotoxins | Emerging Cross-Sectional Technologies | 43 | Active |
| US7709228B2 | Activatable recombinant neurotoxins | Emerging Cross-Sectional Technologies | 25 | Active |
| US6911541B2 | Promoter fragment that is recognized by the product of the tobacco Nic gene | Chemistry; Metallurgy | 23 | Expired |
| US8802096B2 | Anti-C5a binding antibodies with high block activity | Chemistry; Metallurgy | 17 | Active |
| US9073983B2 | Anti-C5A binding moieties with high blocking activity | Chemistry; Metallurgy | 12 | Active |
| US9458233B2 | Anti-C5a binding moieties with high blocking activity | Chemistry; Metallurgy | 11 | Active |
| US7985411B2 | Activatable recombinant neurotoxins | Emerging Cross-Sectional Technologies | 9 | Active |
| US7067134B1 | HIV vaccine | Chemistry; Metallurgy | 9 | Expired |
| US7959933B2 | Activatable recombinant neurotoxins | Emerging Cross-Sectional Technologies | 9 | Active |
| US7192771B2 | Plant promoter sequence | Chemistry; Metallurgy | 8 | Expired |
| US7897744B2 | SARS virus nucleotide and amino acid sequences and uses thereof | Physics | 5 | Active |
| US10774136B2 | Anti-C5a binding moieties with high blocking activity | Chemistry; Metallurgy | 5 | Active |
| US7994389B2 | Soybean genes for resistance to Aphis glycines | Emerging Cross-Sectional Technologies | 4 | Active |
| US10703775B2 | Method of purifying antifungal compounds and exopolysaccharides from a microbial cell culture | Chemistry; Metallurgy | 3 | Active |
| US11571446B2 | Gut microbiota and treatment of cancer | Human Necessities | 1 | Active |
| US9074181B2 | Suspension culture of human embryonic stem cells | Chemistry; Metallurgy | 1 | Active |
| US7189570B2 | Putrescine-n-methyltransferase promoter | Chemistry; Metallurgy | 0 | Expired |
| US11576387B2 | Method for the preparation of bread by compounding natural yeast | Chemistry; Metallurgy | 0 | Active |
| US8936925B2 | Reconstitution of 5-enolpyruvylshikimate-3-phosphate synthase activity by fragment complementation | Chemistry; Metallurgy | 0 | Active |
| US12226424B2 | Target protein degradation compounds, their anti-tumor use, their intermediates and use of intermediates | Chemistry; Metallurgy | 0 | Active |
| US10011867B2 | Targeted sequencing technique for whole genome DNA methylation | Chemistry; Metallurgy | 0 | Active |
| US12329784B2 | Gut microbiota and treatment of cancer | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.